Aims and Scope

Clinical Oncology Journal (ISSN 2766-9882) primarily focuses on collaborating with young ongoing professionals/researchers, academicians, all over the geographic, professional, and academic borders to improve cancer care helping underserved patients across the world. We publish academic articles on biomarker-based immunotherapeutic studies and immune checkpoint inhibitor treatment studies of a modern-day precise medicine.

Our journal plays a vital role as a premier source for the scientific community by publishing advancements and innovations of scientific knowledge in the wide range of research and issues raised during practice. Clinical oncology journal accepts and publishes the articles according to the international publishing standards and never compromises on the publication ethics in processing the articles. The entire processing of articles are monitored by editors who are relevant in the particular field, and the journal follows a double-blind peer-review process to ensure the quality of the publication.

Clinical Oncology Journal (ISSN 2766-9882) aims to share a mission to raise awareness of cancer disease with International cancer research and cancer care societies. We publish updated news and research reports along with the clinical trials of Oncology surgeons.

These include modern medical science innovations and immunotherapeutics, such as targeted hormonal therapy, chemotherapy, radiation therapy, and precise medicine. We also cover a wide range of oncology discipline such as,